Lung Cancer Screening Eligibility and Use: A Population Health Perspective of One Community
- 20 September 2021
- journal article
- Published by North Carolina Institute of Medicine in North Carolina Medical Journal
- Vol. 82 (5), 321-326
- https://doi.org/10.18043/ncm.82.5.321
Abstract
BACKGROUND Low-dose chest CT (LDCT) is the only effective screening test for lung cancer. Annual lung cancer screening (LCS) is recommended by the US Preventive Services Task Force (USPSTF) for individuals at high risk for primary lung neoplasm. METHODS We retrospectively identified patients receiving LCS from January 2016 through March 2018 whose residential addresses were within our health center’s county. We estimated driving distance from the patient’s address to our health center and obtained sociodemographic characteristics from the electronic health record (EHR). The census-tract-level LCS-eligible population size was estimated, and their population characteristics determined via US Census Bureau, Centers for Disease Control and Prevention (CDC), and Behavioral Risk Factor Surveillance System (BRFSS) data. The Cochran-Mantel-Haenszel test was used to determine differences amongst the LCS-eligible and LCS-enrolled populations. Multivariable regression was used to determine the effects of sociodemographic characteristics on LCS eligibility. RESULTS There was modest correlation between census-tract-level LCS-eligible population size and LCS enrollment (r = 0.68, P < .001). 5.9% (364/6185) of the estimated LCS-eligible population in our county received LCS, with census-tract LCS rates ranging from 1.5% to 12.5%. Nonwhite race status (Hispanic and African American) was associated with decreased likelihood of LCS enrollment compared to White race (OR = 95% CI, 0.765 [0.61, 0.95] and 0.031 [0.008, 0.124], respectively). Older age, Medicaid, and uninsured statuses were positively correlated with LCS eligibility (P ≤ .01). LIMITATIONS This analysis comprises a single county. Other LCS facilities within our health system in neighboring counties, as well as individuals receiving LCS outside of our health system, are not captured. CONCLUSIONS The uptake of LCS remains low, with disproportionately lower screening rates amongst Hispanic and African American populations. Medicaid and uninsured patients in our community are also more likely to be LCS-eligible. These populations may be targets for interventions aimed at increasing LCS awareness and uptake.Keywords
This publication has 29 references indexed in Scilit:
- Racial and Ethnic Differences in Lung Cancer Surgical Stage: An STS Database StudyThe Thoracic and Cardiovascular Surgeon, 2015
- Health Disparities and Cancer: Racial Disparities in Cancer Mortality in the United States, 2000–2010Frontiers in Public Health, 2015
- Implementing Lung Cancer Screening Using Low-Dose Computed Tomography: Recommendations From an Expert PanelJournal of Oncology Practice, 2015
- Developing small-area predictions for smoking and obesity prevalence in the United States for use in Environmental Public Health TrackingEnvironmental Research, 2014
- Survival Disparities in Non–Small Cell Lung Cancer by Race, Ethnicity, and Socioeconomic StatusThe Cancer Journal, 2014
- Issues with implementing a high‐quality lung cancer screening programCA: A Cancer Journal for Clinicians, 2014
- Screening for Lung Cancer: U.S. Preventive Services Task Force Recommendation StatementAnnals of Internal Medicine, 2014
- Results of the Two Incidence Screenings in the National Lung Screening TrialThe New England Journal of Medicine, 2013
- Spatial Access to Health Care Services and Disparities in Colorectal Cancer Stage at Diagnosis in TexasThe Professional Geographer, 2013
- Low socioeconomic status is a poor prognostic factor for survival in stage I nonsmall cell lung cancer and is independent of surgical treatment, race, and marital statusCancer, 2008